Zydus Lifesciences has informed that it enclosed disclosure in prescribed Form C under regulation 7(2) of Insider Trading received from Vishal J. Gor, Sr. Vice President -Corporate Finance of the Company with respect to sale of 862 equity shares of Re 1 each in the open market.
The above information is a part of company’s filings submitted to BSE.